Explore 3 Stock Ideas & Industry Insights Download Free Report

800-234-336
Shopping Cart 0
countryflagNZ
Login

Deltagen Inc

Healthcare US DGEN

0.0001USD
0.00(0%)

Last update at 2026-06-18T13:30:00Z

Day Range

0.00010.0001
LowHigh

52 Week Range

0.00010.0001
LowHigh

Fundamentals

  • Previous Close 0.0001
  • Market Cap2.75M
  • Volume0
  • P/E Ratio-
  • Dividend Yield-%
  • Revenue TTM0.77M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.77M
  • Diluted EPS TTM-

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2015-12-31 2014-12-31 2013-12-31 2012-12-31 2010-12-31
Type yearly yearly yearly yearly yearly
Date 2015-12-31 2014-12-31 2013-12-31 2012-12-31 2010-12-31
Income before tax -0.04600M 0.16M -4.41800M -1.16500M -0.68500M
Minority interest 0.00000M 0.00000M 0.00000M 0.00000M -
Net income -0.04600M 0.16M -4.41800M -1.16500M -0.68500M
Selling general administrative 0.00000M 0.00000M 0.00000M 0.00000M -
Selling and marketing expenses - - - - -
Gross profit 0.77M 0.77M 0.66M 0.71M -
Reconciled depreciation - - - - -
Ebit -0.04600M 0.16M 0.11M 0.00100M -0.68500M
Ebitda - - - - -0.67300M
Depreciation and amortization - - - - 0.01M
Non operating income net other - - - - -
Operating income -0.04600M 0.16M 0.11M 0.00100M -0.69400M
Other operating expenses 0.81M 0.61M 0.55M 0.71M 2.68M
Interest expense 0.00000M 0.00000M 0.00000M 0.00000M -
Tax provision - - - - -
Interest income - - - - -
Net interest income - - - - -
Extraordinary items 0.00000M 0.00000M 0.00000M 0.00000M -
Non recurring 0.00000M 0.00000M 0.00000M 0.00000M -
Other items 0.00000M 0.00000M 0.00000M 0.00000M -
Income tax expense 0.00000M 0.00000M 0.00000M 0.00000M -
Total revenue 0.77M 0.87M 1.02M 1.05M 1.99M
Total operating expenses 0.82M 0.71M 0.91M 1.05M 2.67M
Cost of revenue 0.00400M 0.10M 0.36M 0.34M -
Total other income expense net 0.00000M 0.00000M -4.53000M -1.16600M 0.00900M
Discontinued operations 0.00000M 0.00000M 0.00000M 0.00000M -
Net income from continuing ops -0.04600M 0.16M -4.41800M -1.16500M -
Net income applicable to common shares -0.04600M 0.16M -4.41800M -1.16500M -
Preferred stock and other adjustments - - - - -
Breakdown 2015-12-31 2014-12-31 2013-12-31 2012-12-31 2010-12-31
Type yearly yearly yearly yearly yearly
Date 2015-12-31 2014-12-31 2013-12-31 2012-12-31 2010-12-31
Total assets 1.80M 1.84M 2.04M 6.45M 7.15M
Intangible assets 0.00000M 0.00000M 0.00000M 0.00000M -
Earning assets - - - - -
Other current assets 0.00100M 0.00000M -0.00100M 0.00000M 0.56M
Total liab 0.13M 0.12M 0.44M 0.40M 0.32M
Total stockholder equity 1.67M 1.72M 1.60M 6.05M 6.83M
Deferred long term liab 0.00000M 0.00000M 0.00000M 0.00000M -
Other current liab 0.00000M 0.00000M 0.00000M 0.00000M 0.09M
Common stock 0.04M 0.04M 0.04M 0.04M 0.04M
Capital stock - - - - -
Retained earnings -228.46800M -228.42300M -228.57900M -224.16000M -223.36700M
Other liab 0.00000M 0.00000M 0.00000M 0.00000M -
Good will 0.00000M 0.00000M 0.00000M 0.00000M 0.22M
Other assets 1.59M 1.59M 1.59M 1.59M -
Cash 0.05M 0.02M 0.09M 0.10M 3.53M
Cash and equivalents - - - - -
Total current liabilities 0.13M 0.10M 0.44M 0.30M 0.32M
Current deferred revenue - - - - -
Net debt - - - - -3.53000M
Short term debt 0.00000M 0.02M 0.00000M 0.11M -
Short long term debt 0.00000M 0.02M 0.00000M 0.11M -
Short long term debt total - - - - -
Other stockholder equity 0.40M 0.40M 0.40M 0.40M 229.76M
Property plant equipment 0.03M 0.03M 0.03M 0.03M -
Total current assets 0.19M 0.23M 0.43M 0.31M 4.37M
Long term investments 0.00000M 0.00000M 0.00000M 4.53M -
Net tangible assets 1.67M 1.72M 1.60M 6.05M -
Short term investments 0.00000M 0.00000M 0.00000M 0.00000M -
Net receivables 0.12M 0.19M 0.33M 0.16M 0.29M
Long term debt 0.00000M 0.03M 0.00000M 0.10M -
Inventory 0.00000M 0.00000M 0.00000M 0.00000M -
Accounts payable 0.12M 0.09M 0.28M 0.28M 0.23M
Total permanent equity 0.00000M 0.00000M 0.00000M 0.00000M -
Noncontrolling interest in consolidated entity 0.00000M 0.00000M 0.00000M 0.00000M -
Temporary equity redeemable noncontrolling interests 0.00000M 0.00000M 0.00000M 0.00000M -
Accumulated other comprehensive income 0.00000M 0.00000M 0.00000M 0.00000M 0.40M
Additional paid in capital 0.00000M 0.00000M 0.00000M 0.00000M -
Common stock total equity 0.00000M 0.00000M 0.00000M 0.00000M -
Preferred stock total equity 0.00000M 0.00000M 0.00000M 0.00000M -
Retained earnings total equity 0.00000M 0.00000M 0.00000M 0.00000M -
Treasury stock 0.00000M 0.00000M 0.00000M 0.00000M -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total - - - - 2.78M
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2015-12-31 2014-12-31 2013-12-31 2012-12-31 2010-12-31
Type yearly yearly yearly yearly yearly
Date 2015-12-31 2014-12-31 2013-12-31 2012-12-31 2010-12-31
Investments 0.00000M 0.00000M 0.00000M 0.00000M -
Change to liabilities 0.04M -0.19500M 0.00700M -0.22700M -
Total cashflows from investing activities 0.00000M 0.00000M 0.00000M 0.00000M -
Net borrowings 0.00000M 0.00000M 0.00000M -1.27500M -
Total cash from financing activities 0.00000M -0.04000M -0.04000M -0.64900M -
Change to operating activities -0.03000M -0.12200M 0.03M 0.64M -
Net income -0.04600M 0.16M -4.41800M -1.16500M -0.68500M
Change in cash 0.03M -0.06200M -0.01000M -1.31400M -
Begin period cash flow - - - - 5.70M
End period cash flow - - - - 3.53M
Total cash from operating activities 0.02M -0.02200M -0.01000M -0.66600M -2.17500M
Issuance of capital stock - - - - -
Depreciation 0.00000M 0.00000M 0.00000M 0.17M 0.01M
Other cashflows from investing activities 0.00000M 0.00000M 0.00000M 0.00000M -
Dividends paid 0.00000M 0.00000M 0.00000M 0.00000M -
Change to inventory 0.00000M 0.00000M 0.00000M 0.00000M -
Change to account receivables 0.06M 0.14M -0.16300M -0.08700M -0.15700M
Sale purchase of stock 0.00000M 0.00000M 0.00000M 2.05M -
Other cashflows from financing activities 0.00000M 0.00000M 0.00000M -1.26900M -1.49700M
Change to netincome 0.00000M 0.00000M 4.53M -0.00100M -
Capital expenditures 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital - - - - -1.51100M
Stock based compensation - - - - -
Other non cash items - - - - 0.00900M
Free cash flow - - - - -2.17500M

Peer Comparison

Sector: Healthcare Industry: Medical Instruments & Supplies

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
DGEN
Deltagen Inc		 - -% 0.0001 - 21.93 3.57 - 0.01 0.12
ISRG
Intuitive Surgical Inc		 -3.83 0.94% 402.95 73.05 61.73 19.15 10.25 18.41 59.92
ESLOF
EssilorLuxottica Société anonyme		 -13.86 6.73% 192.00 44.84 27.62 4.07 2.49 3.71 16.04
ESLOY
Essilor International SA		 -5.56 5.46% 96.36 41.68 27.25 3.94 2.45 3.71 16.04
BDX
Becton Dickinson and Company		 -3.27 2.27% 140.71 25.56 12.48 2.59 1.76 2.89 12.55

Reports Covered

Stock Research & News

View All

Profile

Deltagen Inc. provides drug discovery tools and services to the biopharmaceutical industry. The company offers a suite of programs designed to enhance the efficiency of drug discovery, including access to biological models, as well as small-molecule and secreted protein drug targets. It also provides target validation data in the areas of immunology and metabolic diseases. The company was incorporated in 1999 and is headquartered in San Mateo, California.

Deltagen Inc

1900 South Norfolk Street, San Mateo, CA, United States, 94403

Key Executives

Name Title Year Born
Dr. Robert J. Driscoll CEO, Pres, Sec. & Director 1966
Mr. Daniel Ratto Chief Financial Officer 1958
Dr. Robert J. Driscoll J.D., Ph.D. CEO, President, Secretary & Director 1966

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.